Publication: Metabolic Syndrome among Stable Chronic Obstructive Pulmonary Disease Patients Visiting Outpatient Department of a Tertiary care centre: A Descriptive Cross-sectional Study
| creativeworkseries.issn | JNMA Print ISSN: 0028-2715; Online ISSN: 1815-672X | |
| dc.contributor.author | Baniya, Santosh | |
| dc.contributor.author | Shrestha, Tirtha Man | |
| dc.contributor.author | Pant, Pankaj | |
| dc.contributor.author | Aacharya, Ramesh Prasad | |
| dc.date.accessioned | 2025-09-26T06:33:38Z | |
| dc.date.available | 2025-09-26T06:33:38Z | |
| dc.date.issued | 2023 | |
| dc.description | Santosh Baniya Department of General Practice and Emergency Medicine, Pokhara Academy of Health Sciences, Ramghat, Pokhara, Nepal Tirtha Man Shrestha Department of General Practice and Emergency Medicine, Institute of Medicine, Tribhuvan University Teaching Hospital, Maharajgunj, Kathmandu, Nepal Pankaj Pant Department of Pulmonology and Critical Care, Tribhuvan University Teaching Hospital, Maharajgunj, Kathmandu, Nepal Ramesh Prasad Aacharya Department of General Practice and Emergency Medicine, Institute of Medicine, Tribhuvan University Teaching Hospital, Maharajgunj, Kathmandu, Nepal | |
| dc.description.abstract | Abstract Introduction: Metabolic syndrome; a constellation of obesity, hypertension, and disturbances of lipid and carbohydrate metabolism is a common phenomenon in chronic obstructive pulmonary disease. Systemic inflammation plays an important role in both conditions. The aim of this study was to find out the prevalence of metabolic syndrome among stable chronic obstructive pulmonary disease patients visiting the outpatient Department of a tertiary care centre. Methods: A descriptive cross-sectional study was done in the outpatient Department of Pulmonology and General Practice from 1 August 2019 to 31 December 2020. Ethical approval was obtained from Institutional Review Committee [Registration number: 5/(6-11)E2/076/077]. Convenience sampling method was used. Point estimate and 95% Confidence Interval were calculated. Results: Among 57 patients with stable chronic obstructive pulmonary disease, the prevalence of metabolic syndrome was 22 (38.59%) (27.48-49.70, 90% Confidence Interval). The prevalence of metabolic syndrome in patients with Global Initiative for Obstructive Lung Disease stages 1, 2, 3, and 4 were 6 (27.27%), 9 (40.90%), 6 (27.27%) and 1 (4.54%) respectively. Conclusions: The prevalence of metabolic syndrome was similar to the other studies done in similar settings. The screening of metabolic syndrome is necessary and stratification for cardiovascular disease risk is important for timely intervention to prevent and decrease morbidities and mortalities. | |
| dc.identifier | https://doi.org/10.31729/jnma.7719 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14572/2393 | |
| dc.language.iso | en_US | |
| dc.publisher | Nepal Medical Association | |
| dc.subject | Chronic obstructive pulmonary disease | |
| dc.subject | C-reactive Protein | |
| dc.subject | Metabolic syndrome | |
| dc.title | Metabolic Syndrome among Stable Chronic Obstructive Pulmonary Disease Patients Visiting Outpatient Department of a Tertiary care centre: A Descriptive Cross-sectional Study | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.article.type | Original Article | |
| oaire.citation.endPage | 358 | |
| oaire.citation.startPage | 355 | |
| relation.isJournalIssueOfPublication | cb29f96c-a94f-4864-95b6-9f7f36256766 | |
| relation.isJournalIssueOfPublication.latestForDiscovery | cb29f96c-a94f-4864-95b6-9f7f36256766 | |
| relation.isJournalOfPublication | e6e146a0-0ece-4aba-aa0a-6ccfbd10a12a |